Despite considerable progress in tackling cardiovascular disease over the past 50 years, many gaps in the quality of care for cardiovascular disease remain. Multiple missed opportunities have been identified at every step in the prevention and treatment of cardiovascular disease, such as failure to make risk factor modifications, failure to diagnose cardiovascular disease, and failure to use…
Dr. Harlan Krumholz, incoming editor of JACC, shares his vision, strategy, and goals for the journal. He welcomes authors and readers to join JACC and…
The agency faulted the device maker for delayed notice of mounting complications, citing increasing reports of how use of the device perforated the walls of…
Editorial Boards for JACC and JACC: Clinical Electrophysiology (JACC: CEP) will integrate their efforts to attract and publish the best electrophysiology (EP) content and produce…
Editorial Boards for JACC and JACC: Clinical Electrophysiology (JACC: CEP) will integrate their efforts to attract and publish the best electrophysiology (EP) content and produce…
Incoming JACC Editor-in-Chief Harlan M. Krumholz, MD, SM, FACC, has announced his new slate of Editors, who will position the journal to achieve its vision…
Incoming JACC Editor-in-Chief Harlan M. Krumholz, MD, SM, FACC, has announced his new slate of Editors, who will position the journal to achieve its vision…
Yale Medicine experts discuss the latest news on how semaglutide (Wegovy), an anti-obesity medication, could help lower cardiac risk.
In January 2024, the Government Accountability Office (GAO) formally accepted a request from Congress to review FDA’s oversight of device recalls. To inform the forthcoming…
In January 2024, the Government Accountability Office (GAO) formally accepted a request from Congress to review FDA’s oversight of device recalls. To inform the forthcoming…
Hint: It’s not you. Nor do they belong to taxpayers, who paid for their collection.
